N

NovaBay Pharmaceuticals
D

NBY

0.57000
USD
-0.02
(-3.39%)
مغلق
حجم التداول
0
الربح لكل سهم
-1
العائد الربحي
-
P/E
0
حجم السوق
3,315,236
أصول ذات صلة
ABT
ABT
-0.240
(-0.18%)
131.240 USD
AZN
AZN
-0.110
(-0.16%)
70.410 USD
GSK
GSK
-0.560
(-1.43%)
38.690 USD
JNJ
JNJ
0.360
(0.24%)
152.930 USD
MRK
MRK
-0.220
(-0.28%)
77.600 USD
NVS
NVS
0.240
(0.21%)
112.750 USD
PFE
PFE
0.110
(0.47%)
23.330 USD
P
PLX
-0.05000
(-3.01%)
1.61000 USD
SNY
SNY
-0.515
(-0.98%)
51.995 USD
المزيد
الأخبار المقالات

العنوان: NovaBay Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.